| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |